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A thunderstorm can be viewed as a consequence of Zeus’ anger or of a difference of 
potential between the clouds and the earth. A disease can be seen as the result of a spell cast on 
the patient or of an infection by a virus. In all cases, however, one watches the visible effect of 
some hidden cause related to the whole set of invisible forces that are supposed to run the world. 
- François Jacob (Evolution and Tinkering, Science, 1977)  
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Advancing Metabolic Engineering through Combination of Systems Biology and Adaptive Evolution 
KUK-KI HONG 
Systems and Synthetic Biology Group 
Department of Chemical and Biological Engineering, Chalmers University of Technology 
ABSTRACT 
Understanding evolutionary strategies of microorganisms may provide opportunities for 
advanced strain development with the aim to produce valuable bio-products from renewable 
biomass resources. Through evolutionary processes, microorganisms can attain new traits 
associated with genetic changes that may be useful for the construction of improved strains. 
Therefore, the characterization of evolutionary strategies may result in identification of the 
molecular and genetic changes underlying newly obtained traits, and can hereby become an 
essential step in strain development. However, so far the depth of analysis has limited the range 
of comprehension. This thesis applied genome-wide analyses such as transcriptome, metabolome 
and whole-genome sequencing to investigate the evolutionary strategies of the yeast 
Saccharomyces cerevisiae. Three evolved mutants were independently generated by adaptive 
evolution on galactose minimal media to obtain the trait of improved galactose utilization by 
yeast. Those strains expressed higher galactose utilization rates than a reference strain in terms of 
both maximum specific growth rate and specific galactose uptake rate. Application of the 
genome-scale comparative analyses employing engineered strains as controls elucidated unique 
changes obtained by adaptive evolution. Molecular bases referred from the changes of 
transcriptome and metabolome were located around galactose metabolism, while genetic bases 
from whole-genome sequencing showed no mutations in those changes. Common mutations 
among the evolved mutants were identified in the Ras/PKA signaling pathway. Those mutations 
were placed on the reference strain background and their effects were evaluated by comparison 
with the evolved mutants. One of the site-directed mutants showed even higher specific galactose 
uptake rate than the evolved mutants, and just few number of genetic and molecular changes were 
enough to recover complete the adaptive phenotype. These results indicate that identification of 
key mutations provide new strategies for further metabolic engineering of strains. In addition, the 
pleiotropy of obtained phenotype that is improved galactose availability was tested. When the 
galactose-evolved mutants were cultured on glucose that is the most favorite carbon source of 
yeast, those mutants showed reduction of glucose utilization. Genome-wide analyses and site-
directed mutagenesis were applied again to understand underlying molecular and genetic bases of 
this trade-off in carbon utilization. The results indicated that loosening of tight glucose regulation 
was likely the reason of increased galactose availability. The implications of evolutionary 
strategies and the impact of genome-scale analyses on characterization of evolved mutants are 
discussed.  
 
Key words: metabolic engineering, evolutionary engineering, systems biology, galactose 
utilization, Ras/PKA signaling pathway, pleiotropy of evolutionary strategies 
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1. INTRODUCTION 
1.1. Yeast Saccharomyces cerevisiae for future biorefineries 
Even before recognizing the presence of microorganisms, mankind has used microbial 
fermentation to produce beverages and foods. Since 1920 industrial microbial fermentation has 
been used to manufacture organic acids, amino acids and vitamins (Kinoshita, et al., 1957, 
Nakayama, et al., 1961, Demain, 2000). The advent of genetic engineering in the 1970s led to the 
use of microbial fermentation for the production of pharmaceutical proteins such as human 
insulin and human growth hormone (Goeddel, et al., 1979, Johnson, 1983). Currently, the world 
is confronting serious challenges such as climate changes due to greenhouse gas emission and the 
depletion of petroleum oil causing limitation of energy and chemical resources. Microbial 
fermentation is considered as one of the possible solutions to these grand challenges, because it 
uses renewable biomass that can also absorb carbon dioxide during growth, and produce fuels and 
chemicals in eco-friendly processes (Lipinsky, 1981, Werpy & Petersen, 2004, Vennestrom, et al., 
2011). There are already several successful industrial trials to produce chemicals from biomass 
by microbial fermentations (Table 1-1).  
 
Table 1-1. Chemicals are recently produced from biomass, including major players and host 
strains 
 
Chemicals Products/Uses Major players Host strains 
succinic acid 
plastics, chemical 
intermediates, solvents, 
polyurethanes, plasticizers 
BASF/Purac(CSM) 
Basfia 
succiniciproducens 
 (from Bovin rumen, 
Gram-negative) 
3-hydroxypropionic 
acid 
acrylic acid: plastics, fiber, 
coatings, paints, super-
absorbent diapers 
Novozymes/Cargill 
Escherichia coli 
Saccharomyces 
cerevisiae 
isoprene synthetic rubber 
Genencor(Danisco) 
/Goodyear 
Bacillus subtilis, 
Escherichia coli, 
Pantoea citrea, 
Trichoderma reesei, 
Yarrowia lipolytica 
lactic acid plastics, synthetic fibers Cargill 
Kluyveromyces 
marxianus 
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lactic acid plastics, synthetic fibers Purac(CSM)/Arkema 
thermophilic Bacillus, 
thermophilic Geobacillus 
1,3-propanediol 
engine coolant, cosmetics, 
surfactants, emulsifiers, 
preservatives, polymers 
Dupont/Tate&Lyle Escherichia coli 
propylene Thermoplastic Braskem/Novozymes 
Propionibacterium 
acidipropionici 
 
Strain development is a pre-requisite to materialize bio-based chemical production, as it is 
directly related to not only improving yield, titer, and productivity of products, but also utilizing 
cheap raw materials efficiently (Tyo, et al., 2007, Patnaik, 2008, Elkins, et al., 2010). The yeast 
Saccharomyces cerevisiae has been used for the production of a wide range of industrial products 
due to its tolerance to industrial conditions and the vast amount of knowledge about its 
physiology, biochemistry, genetics, and long history of fermentation (Pronk, 2002, van Maris, et 
al., 2006, Nevoigt, 2008, Nielsen & Jewett, 2008, Krivoruchko, et al., 2011). Thus, its products 
range and available current technologies are quite broad (Table 1-2).  
 
Table 1-2. Examples of products and strains of S.cerevisiae  
(More detailed explanation is in Paper IV.) 
Categories Products Strains References 
Biofuels 
Ethanol CEN.PK102-3A (MATa ura3 leu2)  
(Guadalupe 
Medina, et al., 
2010) 
Biobutanol 
CEN.PK 2-1C (MATα leu2-3, 112 his3-Δ1 ura3-
52 trp1-289 MAL2-8(Con) MAL3 SUC3) 
(Chen, et al., 
2011) 
Biodiesels 
YPH499 (MATa ura3-52 lys2-801_amber 
ade2-101_ochre trp1-D63 his3-D200 leu2-D1) 
(Yu, et al., 2012) 
Bisabolene BY4742 (MATα his3D1 leu2D0 lys2D0 ura3D0) 
(Peralta-Yahya, et 
al., 2011) 
Bulk 
chemicals 
1,2-propanediol 
NOY386αA (MATα ura3-52 lys2-801 trp1-Δ63 
his3-Δ200 leu2-Δ1), BWG1-7a (MATa ade1-
100 his4-519 leu2-3,112 ura3-52 GAL+) 
(Lee & Dasilva, 
2006) 
L-Lactic acid 
CEN. PK2-1C (MATa ura3-52 trp1-289 leu2-
3,112 his3Ä1 MAL2-8C SUC2) 
(Zhao, et al., 
2011) 
Polyhydroxy-
alkanoates 
BY4743 (MATa/α his3Δ1/his3Δ1 
leu2Δ0/leu2Δ0 ura3Δ0/ura3Δ0) 
(Zhang, et al., 
2006) 
Intro. Yeast S. cerevisiae for future biorefineries 
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Pyruvic acid CEN.PK113-7D (MATa MAL2-8C, SUC2) 
(van Maris, et al., 
2004) 
 
Succinic acid 
AH22ura3 (MATa ura3Δ leu2-3 leu2-112 his4-
519 can1) 
(Raab, et al., 
2010) 
Fine 
chemicals 
β-amyrin CEN.PK113-7D (MATa MAL2-8C SUC2) 
(Madsen, et al., 
2011) 
β-carotene CEN.PK113-7D (MATa MAL2-8C SUC2) 
(Verwaal, et al., 
2007) 
Amorpha-4, 11- 
diene 
CEN.PK2-1C  (MATa ura3-52 trp1-289 leu2-
3,112 his3Ä1 MAL2-8C SUC2), CEN.PK2-1D  
(MATα ura3-52 trp1-289 leu2-3,112 his3Ä1 
MAL2-8C SUC2) 
(Westfall, et al., 
2012) 
Cinnamoyl 
anthranilates  
BY4742 (MATα his3D1 leu2D0 lys2D0 ura3D0) 
(Eudes, et al., 
2011) 
Cubebol 
CEN.PK113-5D (MATa MAL2-8c SUC2 ura3-
52 ) 
(Asadollahi, et al., 
2010) 
Eicosapentaenoic 
acid (EPA) 
CEN.PK113-5D (MATa MAL2-8c SUC2 ura3-
52 ) 
(Tavares, et al., 
2011) 
Linalool 
BQS252 (MATa ura3-52 (derivative of 
FY1679)) 
(Rico, et al., 2010) 
Methylmalonyl-
coenzyme A 
InvSC1 (MATa, his3delta1, leu2, trp1-289, 
ura3-52 (Invitrogen, Carlsbad, CA, USA))  
BJ5464 (MATα, ura3-52, trp1, leu2-delta1, 
his3-delta200, pep4::HIS3, prb1-delta1.6R, 
can1, GAL). 
(Mutka, et al., 
2006) 
Patchoulol CEN.PK113-13D and CEN.PK113-5D 
(Albertsen, et al., 
2011) 
Resveratrol FY23 (MATa ura3-52 trplA63 leu2A1) 
(Becker, et al., 
2003) 
Vanillin 
 X2180-1A ( MATa his3D1 leu2D0 met15D0 
ura3D0 adh6::LEU2 bgl1::KanMX4 
PTPI1::3DSD [AurC]::HsOMT [NatMX]::ACAR 
[HphMX]) 
(Brochado, et al., 
2010) 
Se-methylseleno-
cysteine 
CEN.PK113-7D (MATa MAL2-8C SUC2) 
(Mapelli, et al., 
2011) 
Non-ribosomal 
peptides 
CEN.PK113-11C (MAT a MAL2-8c SUC2 ura3-
52 his3-D1) 
(Siewers, et al., 
2010) 
Protein 
drugs 
Insulin-like growth 
factor 1 (fhlGF-1) 
GcP3 (MAT a pep4-3 prb1-1122 ura3-52 leu2 
gal2 cir°) 
(Vai, et al., 2000) 
Glucagon 
SY107 (MATα YPS1 Δtpi::LEU2 pep4-3 leu2 
Δura3 cir+) 
(Egel-Mitani, et 
al., 2000) 
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single-chain 
antibodies  (scFv) 
BJ5464 (a ura3-52 trp1 leu2D1 his3D200 
pep40HIS3 prb1D1.6R can1 GAL) 
(Hackel, et al., 
2006) 
 
Hepatitis surface 
antigen  (HBsAg) 
INVSc1 (MATa his3D1 leu2 trp1-289 ura3-52) 
(Vellanki, et al., 
2007) 
 
Parvovirus B19 VP2 
HT393 (MATa leu2-3 leu2-112 ura3Δ5 prb1-1 
prc1-1 pra1-1 pre1-1) 
(Lowin, et al., 
2005) 
 
Epidermal Growth 
factor  (EGF) 
W303-1A (MATa leu2-3,112 his3-11,15 ade2-
1 ura3-1 trp1-1 can1-100), W303-1B (MATα 
leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 
can1-100) 
(Chigira, et al., 
2008) 
 
Immunoglobulin G 
BJ5464a (MATα  ura3-52 leu2~1 his3~200 
pep4::HIS3 prb1~1.6Rcan1 GAL) 
(Rakestraw, et al., 
2009) 
 
Hepatitis B virus 
surface antigen 
(HBsAg) 
S.cerevisiae 2805 (MATα pep4::HIS3 prb-Δ1.6 
his3 ura3-52 gal2 can1) 
(Kim, et al., 2009) 
 
L1 protein of 
human 
papillomavirus 
(HPV) type16  
S.cerevisiae 2805 (MATα pep4::HIS3 prb-Δ1.6 
his3 ura3-52 gal2 can1) 
(Kim, et al., 2010) 
 
There is also extensive research on extending substrate range of this yeast. Resources for 
traditional fermentations have been derived from food crops like corn, wheat and sugar cane, but 
to replace the large amounts of fuels and chemicals currently derived from mineral oil, the use of 
abundant and renewable non-food resources such as switchgrass, corn-cob, bagasse, cheese whey 
and algae is necessary. These biomass resources are composed of diverse kinds of carbon 
structure: polymers (cellulose, starch, xylan), dimers (cellobiose, melibiose, lactose) and 
monomers (glucose, fructose, galactose, arabinose, xylose). Except the hexoses (glucose, fructose, 
galactose) and a few dimers (sucrose, maltose), most of these carbon compounds are not 
endogenously metabolized by S. cerevisiae. Even among the hexoses there are broad differences 
in uptake rate, for example the uptake rate of galactose is much lower than for the other hexoses. 
Therefore, the extension of substrate range of S. cerevisiae provides an excellent opportunity to 
enhance its suitability for biofuels and biochemicals production (van Maris, et al., 2006, Hahn-
Hagerdal, et al., 2007, Nevoigt, 2008, Marie, et al., 2009) (Fig. 1-1). 
(For details, refer to Paper IV.). 
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Fig. 1-1. Overview of relevant carbon sources for yeast fermentation. Heterologous enzymes that 
are currently introduced are summarized for non-utilizable carbon sources (polymer, disaccharide 
and pentose sugar) and non-preferred one (galactose) in S. cerevisiae. 
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1.2. Evolutionary approaches in strain development 
 1.2.1. Evolutionary engineering 
Evolutionary engineering has been traditionally employed for strain development in industry, 
since it can generate specific traits relatively quickly at some level, even though governing 
biological principle may not be evident (Sauer, 2001, Zhang, et al., 2002). The term of 
evolutionary engineering is composed of evolution and engineering. The evolution is a strategy of 
life to adapt to changed environments by natural selection. It is operated through iterative process 
of creating variation in population and selecting proper individuals, consequently a specific trait 
in the population is enriched. This nature’s algorithms can be engineered to make 
biotechnological relevant traits by adjusting the rate of variant generation or defining new 
selection pressures. Therefore, evolutionary engineering is the application of suitable mutagenesis 
and artificially designed selection procedures based on evolutionary mechanisms for strain 
development. Success of evolutionary engineering is, hence, dependent on the ability to design 
mutagenesis and selection conditions (Sauer, 2001, Sonderegger & Sauer, 2003). On the one hand 
random mutagenesis by treatment of mutagens for adjusting mutation rate can be used; it 
generates a broader distribution of mutations in the genome, whereas it makes it more difficult to 
identify beneficial mutations (Sauer, 2001, Ikeda, et al., 2006). On the other hand, the methods 
that can generate traceable mutations in specific regions have been developed, which is called 
genome engineering such as gTME, MAGE and TRMR (Santos & Stephanopoulos, 2008, Boyle 
& Gill, 2012). Another important consideration is to understand the underlying evolution 
mechanisms. Basically, evolutionary engineering relies on evolutionary mechanisms such as 
natural selection or natural preservation (Darwin regretted using selection more frequently than 
preservation). Since natural preservation is the fundamental evolutionary mechanism, this 
concept is used in the design stage of evolutionary engineering. It is also important to be aware of 
other relevant evolutionary mechanisms for strain development such as clonal interference, trade-
offs in traits, negative epistasis (Elena & Lenski, 2003).  
  1.2.2. Inverse metabolic engineering 
Developed strains based on evolutionary engineering can be directly used for industrial 
application. In most cases, only a few specific traits from the mutant strains are needed; however 
Intro. Evolutionary approaches in strain development 
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industrial strains retain the combination of several non-necessary traits simultaneously (Ohnishi, 
et al., 2002, Ikeda, et al., 2006, Ikeda, et al., 2009, Warner, et al., 2009). Therefore, additionally 
the concept of inverse metabolic engineering has been used to make evolutionary engineering 
more useful. Inverse metabolic engineering starts from the identification of genetic basis of 
obtained phenotypes, and completed by transfer of that specific genotype(s) to an industrial strain 
(Bailey, et al., 2002, Ikeda, et al., 2006). The important part in this engineering is the 
identification of the genetic basis; not only in order to enable the transfer of genetic changes 
related to the gained trait, but also the specific trait(s) may not easily be reached to its optimum 
stage because of evolutionary constraints such as negative epistasis, clonal interference; therefore, 
additional engineering based on the identified genetic changes is sometimes required (Warner, et 
al., 2009). For these reasons, the identification of the genetic bases of selected traits is crucial. 
Recently, analytical capabilities that can scan molecular or genetic alteration at genome scale 
have been developed such as omics tools and next generation whole genome sequencing. The 
integration of data generated from those tools is expected to facilitate identification of molecular 
and genetic changes in a more comprehensive fashion (Bro & Nielsen, 2004, Heinemann & Sauer, 
2010, Oud, et al., 2012). 
  1.2.3. Adaptive evolution 
Adaptive evolution is often confused with several similar terms such as adaptive laboratory 
evolution, experimental evolution, and even evolutionary engineering (Sauer, 2001, Elena & 
Lenski, 2003, Conrad, et al., 2011, Portnoy, et al., 2011, Dettman, et al., 2012). Adaptive 
evolution has been used to explain adaptation process of life in biology. When this process can be 
imitated in a laboratory to understand evolution mechanisms or applied to strain development, 
derivative words have been generated. Therefore, adaptive evolution includes both natural 
processes in basic science and a tool in biotechnology. It generates mutations spontaneously 
based on the cell’s endogenous system, and finds a phenotype that have improved fitness to a 
given environment than an ancestor strain, simply by continuous exposure of a population to the 
given environment over a period of time.              
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1.3. Characterization of evolved mutants by genome-scale analysis  
Evolutionary engineering has made commercially successful stories in strain development, 
while the identification of molecular or genetic basis that is involved in phenotypic changes has 
remained an enduring challenge (Ohnishi, et al., 2002,Warner, et al., 2009). There have been 
several efforts to find genetic changes. If biological information about an obtained phenotype is 
present at the pathway level or its regulation, one can check molecular changes in that specific 
pathway. For example, the strain producing high concentration of lysine was characterized based 
on analysis of specific amino acid production pathways (Ikeda, et al., 2006). Key mutations that 
were likely related to release of allosteric regulation were detected, and partial contribution of the 
mutations on the overall phenotype was confirmed. Technological advance has led to 
accumulation of huge amount of knowledge about the biological reactions and regulations, 
facilitating better predictability of relative molecular changes. However, since the changes are 
happened at the whole genome level, and the complexity of biological reactions and regulations 
are still beyond full comprehension, advanced analytical tools that can scan overall molecular 
changes in a system level of a cell are required. During the last decade, omics techniques have 
been developed for genome-wide analysis (Bro & Nielsen, 2004, Herrgard, et al., 2008, 
Petranovic & Vemuri, 2009, Snyder & Gallagher, 2009), and omics approaches established a new 
field in life science, so called Systems Biology that aims to understand  a cell in an holistic view 
by using high-throughput omics data and mathematical models. Systems Biology has been 
implemented by quantifying each level of molecules through whole-genome sequencing, 
transcriptome, proteome, metabolome. Their usefulness and limitation especially for the 
characterization of evolved stains has been recently reviewed (Oud, et al., 2012).  
  1.3.1. Transcriptome analysis for the characterization of evolved strains 
Transcriptome analysis has been routinely used in the last decade because of standardization 
of techniques and data with the support of bioinformatics and models (Bro, et al., 2005, Patil & 
Nielsen, 2005, Bengtsson, et al., 2008, Reimand, et al., 2011). Not only technical maturation, but 
also it has the best coverage among other omics tools (Herrgard, et al., 2008, Reimand, et al., 
2011). The effect of environmental or genetic perturbation can be checked easily by counting the 
number of significantly changed genes. Identified differentially expressed genes between evolved 
mutants and a reference strain are routinely analyzed to find altered pathways, metabolisms, and 
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regulation circuits based on several gene enrichment methods. Therefore, the transcriptome 
analysis can enumerate all possible transcriptional changes that are related to obtained 
phenotypes. Although there are several restrictions such as mixing of transcriptional changes 
between cause and consequence or the desired phenotype related and the experimental condition 
related and so on, transcriptome analysis is essentially useful as a first scan of molecular changes 
in evolved mutants. Additionally, comparison of multi strains or combination with other omics 
data has identified key molecular changes in different mutants (Ideker, et al., 2001, Bro, et al., 
2005, Bengtsson, et al., 2008, Vijayendran, et al., 2008, Hazelwood, et al., 2009).  
  1.3.2. Metabolome analysis for the characterization of evolved strains 
Metabolites play important roles as intermediates of biochemical reactions, which means 
their concentration is a key factor for controlling the reaction rate and they further are involved in 
regulation of the metabolic network through allosteric regulation.  Thus, the level of metabolites 
represents integrative information of the cellular function; they can give critical clues to define 
the phenotype in evolved mutants (Zaldivar, et al., 2002, Kummel, et al., 2010). However, since 
metabolites have very diverse molecular kinds, it is almost impossible to analyze and quantify all 
metabolites in a cell simultaneously unlike the transcriptome. Practically targeted metabolome 
that analyze and quantify selected metabolites therefore has been more frequently used than 
metabolite profiling that tries to increase the number of covering metabolites. Targeted 
metabolomics can get clues from transcriptome data in selected metabolites of interest; and these 
metabolites data can be used to provide additional proof about the link between a desired 
phenotype and molecular changes.     
  1.3.3. Whole-genome sequencing for the characterization of evolved strains 
A genetic change is the first and direct origin of a phenotypic change. Other molecular 
alterations are reflections of the genetic change. Therefore identification of driving genetic 
changes is crucial in inverse metabolic engineering. The importance of the identification of 
genetic changes was mentioned by Bailey et al. in 1996, The power of the technology for 
deciphering the genetic basis for a given phenotype is a critical determinant of the feasibility of 
inverse metabolic engineering (Bailey, et al., 2002). At that time the main limitation was in the 
technical part, since whole genome sequencing was time consuming and had a high cost. 
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However, with next-generation sequencing there has been a revolution in genome sequencing 
technologies and this has reduced the costs many folds (Herring, et al., 2006, Mardis, 2008, 
Shendure & Ji, 2008, Le Crom, et al., 2009, MacLean, et al., 2009, Metzker, 2010, Oud, et al., 
2012). These techniques show the possibility of substantial reduction of the time and cost of 
genome sequencing such that it can be used for routine application similar to transcriptome 
analysis. As an example, the results of sequencing three yeast evolved mutants that were used in 
this thesis are explained in Table 3 and 4. 
 
Table 1-3. The price of the next-generation sequencing (Illumina/Solexa, at 13
th
 January 2010) 
  
Table 1-4. The performance of overall genome sequencing results 
   * 38 bases per sequence read for 2 cycles 
   † Based on genome consensus sequence length of CEN.PK113-7D of 12,155,742 base pairs 
Description  Quntity Unit Price (€) Total Price (€) 
Sample preparation for Genome Analysis,  
Genomic Shotgun 
3 (strains) 544 1632 
Sample preparation with bar-coded adapters 3 34 102 
Sequencing on the Genome Analyzer GAIIx,  
1 paired-ends channel 2x38 bp 
1 3,808 3,808 
Additional bar-coded sample in the same channel,  
paired-ends 
2 136 272 
Bioinformatics analyses 0 340 0 
  Total 5,814 
Sequencing Parameters Mutant A Mutant B Mutant C 
No. of Reads 5,605,504 18,203,846 5,239,106 
Total Bases (bp) * 213,009,152 691,746,148 199,086,028 
Coverage Fold 17 55 16 
Undetermined Base 158,723 86,791 171,362 
Genome percent reference coverage (%)† 98.7 99.3 98.6 
No. of supercontigs  17 17 17 
  Chromosomes 16 16 16 
  Mitochondria 1 1 1 
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In addition, whole genome sequencing of evolved mutants can give genetic proofs for 
evolutionary theories or related questions as Dettman et al. mentioned in 2012, How many 
mutations underlie adaptive evolution, and how are they distributed across the genome and 
through time? Are there general rules or principles governing which genes contribute to 
adaptation, and are certain kinds of genes (e.g. regulatory vs. structural) more likely to be 
targets than others? How common is epistasis among adaptive mutations, and what, if anything, 
does this reveal about the variety of genetic routes to adaptation? How common is parallel 
evolution, where the same mutations evolve repeatedly and independently in response to similar 
selective pressures? (Dettman, et al., 2012) Phenotypic results of mutations are constrained by 
evolutionary genetic context such as epistasis, pleiotropy, hitch-hiking of negative mutation with 
beneficial ones, and so on. Therefore, the whole genome sequencing can give vast amount of 
possibility for increasing our understanding about evolution itself, and prediction our ability to 
use evolutionary strategies in setting the further design in strain development. 
 
 
  
24 
 
1.4. Improving galactose utilization in Saccharomyces cerevisiae 
Galactose metabolism in S. cerevisiae was selected to generate evolutionary strategies and 
explore them through genome-scale analyses in this study. The galactose regulon of S. cerevisiae 
has been extensively investigated, since it has very strict gene expression control properties and it 
is a model system for human disease, galactosemia (Lai, et al., 2009). In addition, yeast strains 
retaining higher galactose utilization ability have been developed for industrial application, 
because galactose is one of the abundant renewable carbon sources (Panesar, et al., 2007, Wi, et 
al., 2009, Kim, et al., 2012). In previous studies, direct genetic engineering approach in galactose 
metabolism showed successful results (Ostergaard, et al., 2000, Bro, et al., 2005, Garcia Sanchez, 
et al., 2010, Lee, et al., 2011). For the next turn in the metabolic engineering cycle, new strategies 
are required.  
  1.4.1. Galactose metabolism in Saccharomyces cerevisiae  
    1.4.1.1. Leloir Pathway 
Even though the molecular structure of galactose is very similar with glucose, more 
enzymatic reactions for galactose utilization are needed to reach glucose-6-phosphate, a precursor 
of glycolysis. And the number of transporter specialized for galactose is just one, while there are 
at least 20 transporters for glucose (Boles & Hollenberg, 1997, Ozcan & Johnston, 1999, 
Wieczorke, et al., 1999). Galactose is metabolized through the Leloir pathway, after the Nobel 
Prize laureate, biochemist Louis Leloir (Cabib, 1970). This pathway is composed of 5 enzymes: 
galactose mutarotase (GAL10), galactokinase (GAL1), galactose-1-phosphate uridyltransferase 
(GAL7), UDP-galactose 4-epimerase (GAL10) and phosphoglucomutase (PGM1/PGM2), and 
expression of those enzymes is controlled by very tight regulatory system consisting of 3 
regulators, Gal3p, Gal4p and Gal80p (Timson, 2007). Further regulation is mediated by Mig1p, 
i.e. glucose is present, Mig1p is de-phosphorylated resulting in its transfer into the nucleus where 
it inhibits expression of GAL1 and GAL4 by binding to upstream repression site (URS) of those 
genes (Timson, 2007) (Fig. 2). Galactose enters the cells mainly through Gal2p, a specific 
galactose transporter. Intracellular galactose is structurally changed to alpha-D-galactose from 
beta-D-galactose by Gal10p, and phosphorylated to galactose-1-phosphate with ATP by galactose 
kinase, Gal1p (Holden, et al., 2003). Galactose-1-phosphate reacts with UDP-glucose resulting in 
Intro. Improving galactose utilization in S.cerevisiae 
25 
 
glucose-1-phosphate and UDP-galactose in a reaction catalyzed by galactose-1-phosphate 
uridyltransferase, Gal7p. This reaction has been studied more intensively because of its relation 
with the human disease galactosemia. Failure of this reaction accumulates galactose-1-phophate, 
which is a marker for diagnostic of the disease (Lai, et al., 2009). The toxicity of high 
concentration of galactose-1-phosphate is not clear, while there have been several proposes about 
the reasons such as inhibition of enzymes and ATP drain (Lai, et al., 2009). UDP-galactose is 
converted into UDP-glucose by a reaction of UDP-galactose 4-epimerase, Gal10p, which is also 
galactose mutarotase. This enzyme has dual activity, which is a unique feature of S. cerevisiae 
and Kluyveromyces fragilis (Thoden & Holden, 2005). Prokaryotes and higher eukaryotes have 
different enzymes to provide these two enzyme activities (Holden, et al., 2003). Since the Leloir 
pathway is a highly conserved system in most organisms, and yeast supposedly occupies a 
position between prokaryotes and higher eukaryotes, this distinctive evolutionary history is an 
open question. In the last step, glucose-1-phosphate is converted into glucose-6-phosphate in a 
reaction of isomerization by Pgm1p and Pgm2p. Pgm2p is responsible for about 80% of the total 
activity (Timson, 2007). Further detailed knowledge about the kinetic properties and structures of 
the enzymes in the Leloir pathway are well explained in biochemistry references (Daugherty, et 
al., 1975, Schell & Wilson, 1977, Segawa & Fukasawa, 1979, Fukasawa, et al., 1980, 
Reifenberger, et al., 1997, Holden, et al., 2003).        
    1.4.1.2. Regulation of GAL genes  
Regulation of GAL genes is an excellent model for studying a regulated eukaryal gene 
expression system (Acar, et al., 2005, Ramsey, et al., 2006, Pannala, et al., 2010). The promoter 
of the GAL genes has been used as a strong expression system with galactose induction (Li, et al., 
2008). Each of the galactose catabolism enzymes Gal1p, Gal7p and Gal10p exist at about 0.3 to 
1.5% of total soluble cytoplasmic protein during growth on galactose (St John & Davis, 1981). 
There are three regulation mechanisms. First, the presence of glucose represses expression of the 
GAL genes through the transcription factor Mig1p (Timson, 2007) (Fig. 2). The Mig1p interacts 
with the transcriptional co-repressor complex Cyc8p (Ssn6p)-Tup1p (Treitel & Carlson, 1995). 
The complex of these three proteins activates the histone deacetylases Hda1p, Hos1p, Hos2p and 
Rpd3p (Davie, et al., 2003), which ensures keeping the chromatin deacetylated, compact, and 
hereby in a transcriptionally inactive state. Second, at high glucose concentrations, the Mig1p is 
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dephosphorylated and stays in the nucleus where it together with the co-repressors block 
expression of the GAL genes, especially GAL4 that is an activator of the GAL genes. Therefore 
the presence of glucose completely blocks expression of the GAL genes.  
 
 
 
 
Fig. 1-2. Galactose pathway (Leloir pathway) and regulation in S. cerevisiae. Pointed arrows 
mean conversion of intracellular metabolites by enzymatic reactions, red arrows indicate 
transcriptional activation. Blue blunt arrows mean inhibition. Dotted lines indicate the direct 
connection between genes and proteins. 
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The absence of glucose, however, is not adequate to induce the galactose metabolizing 
enzymes. The existence of galactose is also necessary (Fig. 2). When external galactose is present 
as a sole carbon source, it can transfer at low rate to the cell through hexose transporters (Hxts), 
which are not specific to galactose as they have very high Km values for galactose transport. 
Galactose transporter gene, GAL2 can be expressed after galactose enters to the cells. Intracellular 
galactose is combined with Gal3p that is a sensor of galactose. Gal3p binds galactose and ATP, 
and then traps the repressor Gal80p. Gal80p is present in the cytoplasm and nucleus, which 
interferes proper binding of Gal4p to the upstream activating sequences (UASGAL) of the GAL 
genes. Thus, in the absence of galactose, the Gal80p blocks Gal4p and hereby prevents induction 
of the GAL gene expression. When only the complex of Gal3p with galactose and ATP is present, 
the blocking of the Gal80p binding to Gal4p is released since this complex catches Gal80p (Yano 
& Fukasawa, 1997). Dual feedback loops have been well elucidated in the galactose control 
system (Ramsey, et al., 2006). The Gal4p induces not only the Gal2p and Gal3p, but also Gal80p. 
Induction of Gal2p and Gal3p is positive feed-back loop because the increased expression of 
Gal2p and Gal3p result in further activation of Gal4p, while induction of Gal80p provides a 
negative feed-back loop since higher expression of Gal80p blocks Gal4p activation (Fig. 2). 
Simultaneous operation of these dual opposite controls has provided an excellent model for 
studies of the dynamics of gene expression regulation in eukaryotes. Third, Lap3p/Gal6p is 
supposed as a possible regulator, because deletion of this gene increases expression of the GAL 
genes (2.5 fold) (Zheng, et al., 1997). The Lap3p is a cysteine protease and the S. cerevisiae 
homologue of this enzyme is Gal6p. The exact mechanism of how Gal6p carries negative 
regulation remains unclear (Zheng, et al., 1997).          
  1.4.2. Galactose as a feedstock in industrial biotechnology 
    1.4.2.1. Galactose content of biomass 
In terms of its use as a carbon and energy source for production of fuels and chemicals 
galactose is mostly found in cheese whey, but with the prospect of using algae as source of 
biomass it is interesting to note that red seaweed has a high content of galactose (Gelidium 
amansii) (Wi, et al., 2009, Kim, et al., 2012). Cheese whey is an eluent from the dairy industry; 
and it contains about 85-95% of the milk volume and 55% of milk nutrients. Two types of the 
cheese whey, sweet (pH 6~7) and acid (pH < 5) are produced dependent on the procedure of 
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casein precipitation. The main components are lactose, whey protein and minerals (Table 5) 
(Jelen, 1979, Siso, 1996, Panesar, et al., 2007). Lactose is a disaccharide sugar composed of 
galactose and glucose through beta-1, 6-linkage. Galactose therefore contains around 22~26 g/l in 
cheese whey.  
Table 1-5. Typical composition of sweet and acid whey (Source: Jelen, 1979, Panesar, et al., 
2007) 
Components Sweet whey (g/l) Acid whey (g/l) 
Total solids 63-70 63-70 
Lactose 45-52 44-46 
Protein 6-10 6-8 
Calcium 0.4-0.6 1.2-1.6 
Phosphate 1-3 2-4.5 
Lactate 2 6.4 
Chloride 1.1 1.1 
Recently algae have been considered as an attractive biomass source for bio-based products, 
due to several advantages compared to terrestrial plant biomass such as high production yield, 
non-food and land usage, little recalcitrant lignin and crystalline cellulose, a higher growth rate 
and others (Kim, et al., 2011, Wargacki, et al., 2012). One algae, the red seaweed (Gelidium 
amansii) has high galactose content even comparable to the amount of glucose (Wi, et al., 2009, 
Kim, et al., 2012). Carbohydrate compositions of different biomass sources are given in Fig. 3. 
 
Fig. 1-3. Composition of non-food biomass (Source: Kim, et al., 2012) 
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    1.4.2.2. Metabolic engineering for improved galactose utilization 
Intensive research on galactose metabolism has generated vast amount of information about 
its metabolic structure and regulation. By exploiting this abundant resource, many elegant 
metabolic engineering approaches have been executed to improve galactose utilization in terms of 
a specific galactose uptake rate. Direct genetic modification of GAL genes and regulatory genes 
were done. Over-expression of GAL catabolic genes was implemented in a high-copy number 
plasmid with different combinations (de Jongh, et al., 2008). Over-expression of the GAL 
catabolic genes was expected to increase flux from galactose to glycolysis; however, the result 
showed reduction of galactose uptake and growth rate. The reason was that changed expression 
level of the GAL genes triggered the fluctuation of concentration of intermediate metabolites in 
the Leloir pathway. One of them, galactose-1-phosphate, was known as a toxic intracellular 
metabolite that interfere with galactose metabolism. Therefore genetic modification was focused 
on regulatory genes. By over-expression of the transcriptional activator, GAL4 and deletion of 
negative regulators, GAL80, MIG1 and GAL6 showed improved galactose uptake rate without 
growth retardation (Ostergaard, et al., 2000). Especially, the triple knock-out mutant (SO16, 
which was used as a control strain in this thesis study) showed the highest specific galactose 
uptake rate. In a follow up study, transcriptome data of these strains was used to find target genes 
that were related to improvement of galactose availability (Bro, et al., 2005). Commonly changed 
genes were screened in galactose related pathways and based on this PGM2, encoding 
phosphoglucomutase, was the only gene that showed significant up-regulation. Application of 
this gene in a high-copy number plasmid clearly showed improvement of galactose utilization 
(this strain was called PGM2, which was used as another control strain in this study). Since this 
gene was supposed to be quite highly expressed even at non-galactose growth condition, the 
result that the rate limiting step enzyme of the Leloir pathway was PGM2 was surprising. When 
galactose-1-phosphate was measured, this strain showed no reduction of this metabolite. Higher 
activity of phosphoglucomutase was checked by checking higher concentration of sugar-6-
phosphates that were considered as products of this enzyme such as galactose-6-phosphate, 
glucose-6-phosphate, mannose-6-phosphate and fructose-6-phosphate. Therefore, even though 
basal expression level of PGM2 was relatively higher than other GAL genes in the wild-type, 
over-expression of this gene was still needed to improve galactose utilization. Another study also 
supported the importance of higher activity of PGM2 for improved galactose utilization (Lee, et 
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al., 2011). In this study, a genomic library was used to find target genes that were related to 
galactose utilization. The constructed library was transformed into the wild-type strain, and 
improved strains were screened. Three beneficial over-expression targets, SEC3, tTUP1, and 
SNR84 were identified. All three targets displayed higher phosphoglucomutase activity. Two of 
them, Sec3p (phosphomannomutase having activity as phosphoglucomutase) and truncated 
Tup1p (complex of Mig1p repressor) were confirmative with the previous work due to the 
function of those genes; while the last target was a new discovery. SNR84 codes for H/ACA box 
small nucleolar RNA, and there is no report on the effect of this gene to galactose metabolism. 
However, higher activity of phosphoglucomutase in the transformant over-expressing SNR84 
proposed a relationship between this gene and galactose metabolism.  
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2. OVERVIEW OF THE THESIS 
The motivation of this study is to apply genome-scale analyses for unraveling the molecular 
and genetic basis of evolutionary strategy of microorganism.  
The galactose metabolism of yeast S. cerevisiae was chosen as a target for evolution, because 
of the following reasons.  
1) It has relevance for developing yeast strains that can use galactose more efficiently like other 
hexose carbon sources; since galactose is an abundant sugar in some renewable resources, and S. 
cerevisiae is a vastly useful strain in industrial applications. 
2) The galactose metabolism in yeast has been extensively studied, which has led to many trials 
for the construction of yeast mutant strains by direct genetic engineering. Consequently, several 
genetic targets related to the improvement of galactose utilization have already been identified, 
which means it is difficult to find new targets. However, rather less attention was paid on 
evolutionary engineering, thus if different targets are generated from an evolutionary approach, 
they are useful for a next round of strain development. 
3) Moreover, which was the main purpose of this thesis; can genome-scale analyses be used for 
the characterization of evolved mutants with the objective to find driving mutations? If this 
answered positively it could open up for wider use of evolutionary strategies in metabolic 
engineering. 
For these reasons, yeast S. cerevisiae CEN.PK113-7D was evolved on galactose minimal 
media through adaptive evolution for 62 days. Three evolved mutants were generated from 
independent populations grown in identical serial transfers. Improved galactose utilization ability 
was confirmed in precisely controlled bioreactors, and genome-scale analyses through 
transcriptome, metabolome and whole-genome analyses were applied to understand evolutionary 
strategies of the galactose-evolved yeast mutants. Furthermore, inverse metabolic engineering 
was applied using identified mutations and new combinations of the genetic changes. The 
comparison of reconstructed strains with the evolved mutants provided a good example how 
evolution and engineering work synergistically in strain development. Further characterization of 
the evolved mutants was done in glucose minimal media to explore the pleiotropy of obtained 
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traits. Molecular and genetic bases of that pleiotropy were elucidated by genome-scale analyses. 
The result increased the understanding of evolutionary strategies of the evolved mutants. 
Consequently, three research studies were designed. 
 
Paper I: Unravelling evolutionary strategies of yeast for improving galactose utilization 
through integrated systems level analysis 
Adaptive evolution generated improved galactose availability with different physiology. The 
molecular and genetic bases that were supposed to be related to improved galactose utilization 
were analyzed. The significant molecular changes in transcripts and metabolites were detected in 
around galactose metabolic pathways, but no mutations were found in those regions. Instead the 
Ras/PKA signaling pathway was detected as a common pathway that had mutations in all the 
evolved mutants. Introduction of one of those mutations in a reference strain partially provided 
the genetic bases of the galactose evolved physiology. It was confirmed that adaptive evolution 
can generate key mutations in unpredictable regions or non-canonical pathways. And the genetic 
basis (mutations) and resulting molecular basis (transcriptome and metabolome) for evolutionary 
changes were found to happen in different regions. 
 
Paper II: Recovery of phenotypes obtained by adaptive evolution through inverse metabolic 
engineering 
Through adaptive evolution and genome-scale analyses, new genetic targets for improving 
galactose utilization were identified. As only a few mutations were selected from many mutations, 
it was necessary to evaluate whether the adaptive phenotype can be recovered by a few mutations. 
Furthermore, it was speculated how inverse metabolic engineering could give more chances 
beyond evolutionary engineering itself for strain development. Two groups of engineered mutants 
were constructed; site-directed mutants that had the identified mutations in the reference strain 
genetic background, and combined mutants that had new combinations by transforming the 
PGM2 over-expression plasmid into the site-directed mutants. Surprisingly, some of the 
constructed strains showed complete recovery of the galactose adaptive phenotype with just one 
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or two genetic modifications. Even one of the reconstructed mutants exhibited further improved 
galactose utilization. These results indicated that far fewer genetic changes were enough to reach 
the same phenotype as the evolved mutants. Therefore inverse metabolic engineering is an 
essential step in the application of evolutionary approaches for strain development, i.e. it can 
enable more strategies for further improvement of desired phenotypes by sieving out beneficial 
mutations from negative ones and generated new artificial combinations of mutations. Detailed 
molecular changes by the mutations were also analyzed using transcriptome analysis and the level 
of a few metabolites. The introduction of key mutations that recovered the adaptive phenotype 
triggered fewer molecular changes compared to the evolved mutants. This result indicated again 
that all molecular changes were not necessary for reaching the same phenotype. 
 
Paper III: Adaptively evolved yeast mutants on galactose show trade-offs in carbon utilization 
on glucose 
The evolved mutants obtained the trait that was an ability to utilize galactose more efficiently 
than the ancestor strain. It was, however, interesting to evaluate whether this trait was associated 
with other effects, i.e. pleiotropy. The galactose-evolved mutants were therefore grown in glucose 
minimal media. Interestingly, these cultivations showed reduced glucose utilization in the 
evolved strains. This means that there is trade-off in galactose utilization and glucose utilization. 
In other words, the evolved mutants likely obtained the increased galactose availability by partly 
losing their ability to very efficiently utilize glucose. The underlying mechanisms of this trade-off 
were studied at the molecular and genetic level by integrated genome-scale analyses. 
Antagonistic pleiotropy was found to be the dominant evolutionary trade-off mechanism. The 
tight regulation system of glucose catabolic repression was loosened by the mutations in 
Ras/PKA signaling pathway and unidentified mutations that may be involved in hexokinase 
regulation and reserve carbohydrates metabolism. Therefore, the glucose utilization ability is 
likely collateral cost for having improved galactose availability in the evolved mutants. This 
finding indicates that genetic context such as pleiotropy causing trade-off in traits should be 
considered, when evolutionary approaches is applied in strain development. 
 
34 
 
  
System level analysis of evolutionary strategy 
35 
 
3. RESULTS AND DISCUSSION 
This section provides a summary of the results, whereas the attached papers in the end of this 
thesis include detailed materials, methods and experimental design with expanded explanations.   
3.1. Molecular and genetic basis of evolutionary strategies of the galactose-evolved mutants 
(Paper I) 
Three evolved populations were generated from S. cerevisiae CEN.PK113-7D, an ancestor 
strain, by three independent serial transfers in a galactose (20g/l) minimal medium for 62 days 
(Fig. 3-1). Single clone isolates were obtained from the last shake flasks, and designated 62A, 
62B and 62C. Two engineered strains, SO16 (gal6∆ gal80∆ mig1∆) and PGM2 (over-expression 
of PGM2 gene), showed improved galactose uptake rates in previous studies were used as control 
strains to elucidate unique strategies of adaptive evolution (Ostergaard, et al., 2000, Bro, et al., 
2005).  
 
Fig. 3-1. Yeast strains used in this study. Engineered mutants were constructed in previous 
studies (Ostergaard, et al., 2000, Bro, et al., 2005) whereas the three evolved mutants were 
generated in this study. 
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Parallel fermentations at aerobic batch mode in precisely controlled bioreactors was performed to 
estimate physiological parameters and to take samples for omics analyses; and transcriptome and 
targeted metabolome analysis were applied to all strains including the two engineered strains; and 
whole-genome analysis were performed on the evolved mutants (Fig. 3-2).  
 
 
Fig. 3-2. Overall flow of the experiments in this study. 6 strains were cultivated in bioreactors, 
and at mid-exponential phase, samples for omics analyses were collected.  
 
Exact identification of improved galactose utilization in the evolved mutants was compulsory, 
since only one colony from each of the populations were selected. Population was composed of 
many diverse individuals, thus it was not sure if the selected colony was really evolved in terms 
of improved galactose utilization. Of course, based on Darwin’s theory, natural preservation, the 
variants that had higher fitness would take more portions in the population; therefore, there was 
high chance to select evolved clones with improved fitness. The purpose of this study was to 
detect evolutionary strategies; hence the confirmation of improved phenotype in the evolved 
mutants was a prerequisite. The evolved mutants achieved improved galactose utilization in terms 
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of a maximum specific growth rate and a specific galactose uptake rate, which were a different 
phenotype compared with the engineered strains (Fig. 3-3). The galactose-evolved mutants 
showed a 24% increase in the maximum specific growth rate and 18 ~ 36% increase in the 
specific galactose uptake rate compared to the reference strain. Interestingly, clear grouping was 
observed between all three evolved mutants and the reference strains in the plot of the specific 
galactose uptake rate versus a specific ethanol production rate (Fig. 3-3B). These two groups 
were separated by different regression curves, which observation means that the adaptive 
evolution has resulted in different phenotypes compared with the engineered strains. 
 
 
 Fig. 3-3. Phenotypic changes of evolved mutant strains 62A, 62B and 62C compared with the 
reference strain CEN.PK113-7D and the two engineered strains SO16 and PGM2. (A) 
Correlation between a maximum specific a growth rate and biomass yield. (B) Correlation 
between a specific galactose uptake rate and a specific ethanol production rate. The regression 
curves of the two lines (from right to left) had a slope of 2.95 and 3.19 and intercept of minus 
7.95 (R2 = 0.99) and minus 10.157 (R2 = 0.98), respectively. Both slope values were around 3, 
which indicated that catabolic repression induced flux re-direction from respiratory metabolism to 
fermentation one, because if there was not that repression, slope should be around 2. 
 
To investigate the molecular basis, firstly transcriptome analysis was used to check overall 
changes, and select significantly altered pathways (Paper I, Fig. 2). Secondly, target metabolome 
was implemented; around 40 metabolites were measured based on the results from the 
transcriptome data and quantified by diverse analytical instruments (Paper I, Fig. 3). Both data 
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sets were used to find the molecular basis for the evolutionary strategies by selecting commonly 
changed metabolisms in all evolved mutants (Fig. 3-4).  
 
 
Fig. 3-4. Changes in the galactose, reserve carbohydrates, and ergosterol metabolism in the 
evolved mutants are illustrated by changes in the concentration of metabolites and fold changes 
of transcriptome compared with the other strains. (A) The concentrations of sugar phosphates, 
storage carbohydrates, and sterols and the ratio of ATP to ADP. (B) Fold changes of all genes 
involved in galactose, reserve carbohydrates, and ergosterol metabolism are compared with the 
reference strain. 
System level analysis of evolutionary strategy 
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Up-regulation of the PGM2 gene and lower concentration of galactose-1-phosphate and glucose-
1-phosphate in the galactose pathway were common in all evolved mutants and engineered 
mutants compared to the reference strain; while up-regulation of genes in reserve carbohydrates 
metabolism and down-regulation of HXK2 that was one of the main glucose catabolic repression 
controllers (Gancedo, 1998), were unique for the evolved mutants. A unique change among 
evolved mutants was found in ergosterol metabolism. The 62B strain only showed up-regulation 
of ERG genes with different ratio of the concentration of ergosterol and dihydroergosterol. In 
terms of fermentation physiology, there was big difference between the 62A and 62C strains; 
however, in terms of transcriptome and metabolome data, they looked almost identical. 62B was 
positioned between them in terms of gross physiology, whereas this evolved mutant showed vast 
differences in the transcriptome and the metabolome. The reason of differences among the 
evolved mutants was not clear, while the common changes of the evolved mutants from the 
reference strain likely explained the molecular bases of evolutionary strategies for improving 
galactose utilization. 
To identify the genetic basis of evolutionary strategies, whole-genome sequencing was 
applied to the evolved mutants (explanation of overall process and raw data are in the 
supplementary data of Paper I). Surprisingly, there were no mutations or duplications in the GAL 
genes and the regulatory genes involved in galactose metabolism including their promoter and 
terminator regions. The reaction step by PGM2 was earlier found as a rate-controlling step in 
galactose metabolism; hence PGM2 over-expression was already proven as a beneficial target for 
metabolic engineering, and several genetic modifications that induced higher expression of this 
gene were also identified. However, mutations from previous studies were not detected in the 
evolved mutants. This result indicated that new mutations that induced up-regulation of PGM2 
were generated. Furthermore, genes of the reserve carbohydrates metabolism and hexokinases 
had no mutations, even though they showed significant alteration in their transcription. 
Exceptionally, the 62B evolved mutant had mutation in the EGR5 gene that seemed to be related 
to changes in ergosterol metabolism (Kelly, et al., 1995) (Table 3-1). No mutations in the 
metabolisms that showed common molecular changes in all the evolved mutants implied that the 
key mutations may be involved in regulatory regions. Common genes, pathway or cellular 
metabolism that had mutation in all three evolved mutants was searched, and it was found that 
there were common mutations in the regulatory, Ras/PKA signaling pathways (Table 3-1). The 
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Ras/PKA signaling pathway has been known to take key role in global regulation of glucose 
sensing and stress response (Estruch, 2000). And PGM2 and UGP1 had STER element in their 
promoter region. Therefore, the mutations in Ras/PKA signaling pathway were suggested as a 
driven mutation that increased galactose utilization by triggering the activation of galactose and 
reserve carbohydrates metabolism (Fig. 3-5). Introduction of mutations in RAS2 genes into a 
reference strain clearly showed the increase of galactose utilization (supplementary data from 
Paper I and Paper II). The 62B unique mutation in the EGR5 gene could explain the changes of 
transcripts and metabolites in the ergosterol pathway; it may also be explicable why this mutant 
showed large differences from other evolved mutants by this mutation. However it was not clear 
how there is a relationship between galactose metabolism and ergosterol pathway.  
 
Table 3-1. Genetic changes in the evolved mutants 
 
Strains Mutations Functions Specific features 
62A RAS2 [Gln
77
  Lys] 
Ras/PKA signaling pathway 
Commonly mutated 
pathway 
62B RAS2 [Asp
112
  Tyr] 
62C CYR1 [Asp
822
  Asn] 
62B ERG5 [Arg
370
  Pro] Ergosterol metabolism Uniquely mutated gene 
 
In conclusion, key genetic changes were identified in non-canonical metabolism, but in the 
Ras/PKA signaling pathway; which meant no mutation detected in galactose metabolism not like 
other direct genetic engineering studies (Ostergaard, et al., 2000, Bro, et al., 2005, Lee, et al., 
2011). And, molecular changes were well related to canonical metabolisms; up-regulation of 
PGM2 in galactose metabolism, and up-regulation of genes in reserve carbohydrates metabolism 
that shared the intermediate of galactose metabolic pathway, i.e. glucose-1-phosphate. 
Hypothetical evolutionary changes were plotted in Fig. 3-5. Therefore, insight about evolutionary 
strategy that results in non-canonical genetic changes with canonical molecular changes could be 
applied as an evolutionary approach in strain development.  
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Fig. 3-5. Summary of evolution changes in the three evolved mutants; 62A, 62B, and 62C. Color 
circular boxes indicate genes having genetic mutations. Color lines indicate activated fluxes 
inferred from transcriptome and metabolome analysis.  
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3.2. Complete recovery of adaptive phenotype through inverse metabolic engineering 
(Paper II) 
The initial purpose of this step was to evaluate the identified mutations. Furthermore, the 
objective was to explore how inverse metabolic engineering was useful in connection with 
evolutionary approaches for strain development. Site-directed mutants and combined mutants 
were constructed for the application of inverse metabolic engineering.  
The genome-scale analyses suggested that the genetic basis for the improved galactose 
utilization could be present in the Ras/PKA signaling pathway, which is not directly involved in 
galactose metabolism, since all the evolved mutants commonly had mutations in this signaling 
pathway. One of the evolved mutants, 62B showed significant changes in ergosterol metabolism 
both at the level of transcripts and metabolites and it carried a mutation in the ERG5 gene. To 
clearly confirm the effect of identified mutations on galactose availability, and to examine how 
much those mutations recovered the adaptive phenotype of the evolved mutants, site-directed 
mutants carrying each of the mutations independently were constructed. In addition, combined 
mutants were constructed by introduction of the known beneficial change (PGM2 overexpression) 
into the site-directed mutants. These combined mutants were designed to generate new 
combination of the genetic basis for improving galactose utilization that was not present in the 
evolved mutants (Table 3-2).  
The gross phenotype of the reconstructed strains was compared to the evolved strains (Fig. 3-
6). The results of the site-directed mutants clearly confirmed the effects of the identified 
mutations on galactose utilization. Two site-directed mutants (RAU and RBU) that had mutations 
in the RAS2 gene showed a significant increase in the maximum specific growth rate and the 
specific galactose uptake rate compared with their reference strain (5DU). Especially, the RAU 
strain that carried the mutation RAS2
Lys 77 
exhibited the highest specific galactose uptake rate 
among all the strains including the evolved mutants. Additionally, when its improvement of 
maximum specific growth rate was compared to the evolved mutants in terms of increased extent 
from each of their reference strains, i.e. RAU from 5DU, and the evolved mutants from 7D, even 
the RAU has a higher relative increase in the specific growth rate than the evolved mutants. 
Interestingly, even though two mutations were positioned in the same gene, their effect on 
galactose utilization was quite different. These results highlighted why the concept of inverse 
Inverse metabolic engineering in systems biology 
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metabolic engineering was important for strain development, because new targets from 
evolutionary engineering should be re-evaluated and there was space for more improvement of 
the desired traits by surveying more mutations in that target gene. The results of the combined 
mutants also showed improvement of the galactose availability. They almost fully recovered the 
adaptive phenotype of the evolved mutants, since the maximum specific growth rate and the 
specific galactose uptake rate were in the same level as the evolved mutants. This result again 
confirmed the importance of inverse metabolic engineering in connection with evolutionary 
approaches for strain development, because the same phenotype was realized with much fewer 
traceable genetic modifications providing more space for new engineering strategies. 
Table 3-2. Reconstructed strains and control strains. Saccharomyces cerevisiae CEN.PK113-5D 
was used to construct site-directed mutants and combined mutants due to its availability of URA3 
marker gene. Prototrophic site-directed mutants (RAU, RBU and EBU) were constructed by 
transformation with the plasmid, pSP-GM2 containing the URA3 gene. The combined mutants 
RAP, RBP and EBP were constructed by transformation of the plasmid pPGM2 into the site-
directed mutants.   
 
Strains Ancestor strains and Genotype Groups References 
7D MATa SUC2 MAL2-8c (CEN.PK113-7D) Reference strain SR&D* 
62A 7D, total no. SNPs: 21 including RAS2 Lys 77  
Evolved  
mutants 
This study 62B 
7D, total no. SNPs: 104 including RAS2 Tyr112, 
ERG5 Pro 370  
62C 7D, total no. SNPs: 29 including CYR1
Asn822 
5D 
MATa SUC2 MAL2-8c ura3-52  
(CEN.PK113-5D)  
SR&D* 
5DU 5D, pSP-GM2(URA3)  Reference strain This study 
RAU 5D, pSP-GM2(URA3); RAS2 Lys 77 (from 62A)  
Site-directed 
mutants 
This study RBU 5D, pSP-GM2(URA3); RAS2 Tyr112 (from 62B)  
EBU 5D, pSP-GM2(URA3); ERG5 Pro 370  (from 62B)  
PGM2 5D, pPGM2(URA3, PPMA1-PGM2)  Engineered mutant Bro et al 2005 
RAP 5D, pPGM2(URA3, PPMA1-PGM2); RAS2 
Lys 77  
Combined 
mutants 
This study RBP 5D, pPGM2(URA3, PPMA1-PGM2); RAS2 
Tyr112  
EBP 5D, pPGM2(URA3, PPMA1-PGM2); ERG5 
Pro 370  
*Scientific Research & Development GmbH, Oberursel, Germany. 
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Fig. 3-6. Data on overall fermentation physiology of the site-directed mutants (RAU, RBU and 
EBU) and the combined mutants (RAP, RBP and EBP) are compared to the reference strains 
5DU, 7D and the engineered strain PGM2, and the corresponding evolved mutants 62A and 62B. 
A: Correlation between the maximum specific growth rate and biomass yield B: Correlation 
between the specific galactose uptake rate and the specific ethanol production rate. Error bars 
represent standard deviation from biological duplicates. 
 
The critical points were, 1) the evolved mutants accumulated many genetic changes that 
seemed to be not necessary for improving galactose utilization, because the reconstructed strains 
showed full recovery of the galactose adaptive phenotype with much fewer genetic changes; 2) 
the combination effect of genetic changes was different from the sum of each of the changes, for 
example, the RAP strain that contained a combination of RAU (RAS2
Lys 77
) and PGM2 
overexpression, showed an increase of the maximum specific growth rate (58% from 5DU); 
however, the sum of each of genetic changes was bigger (69% = 42% (RAU) + 27% (PGM2 
strain)). This phenomenon was much clearer in the specific galactose uptake rate; the 
combination (RAP) showed even reduced value compared with the RAU and PGM2 strains. 
Another combination case, the RBP strain with a combination of RBU and PGM2, also showed a 
negative synergy of beneficial genetic changes even though the extent of the physiological 
changes was different. On the contrast, the combination of ERG5 mutation and PGM2 over-
expression looked like synergetic epistasis. The mutation in the ERG5 gene showed only a small 
effect on galactose utilization. It looked almost neutral when it was solely present, while the 
Inverse metabolic engineering in systems biology 
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combination of this mutation with the over-expression of PGM2 presented the same phenotype 
like the other combined mutants. In evolutionary biology, the accumulation of negative or neutral 
mutations and epistasis among mutations is a well-known event during adaptive evolution (Ikeda, 
et al., 2006, Warner, et al., 2009). That was one of the reasons why cells may not always reach to 
the optimum point of a specific trait by adaptive evolution, especially in asexual reproduction. 
Even for a versatile biological system, natural selection or preservation that could enrich only 
beneficial mutations would possibly require infinite generation time. Thus, to reach the optimum 
point by laboratorial adaptive evolution could be almost impossible (Sauer, 2001). Therefore, 
there is likely space for further improvement of desired traits by removing negative mutations and 
reconstruction of new combinations that may generate synergetic epistasis. Because of these 
reasons, inverse metabolic engineering is an essential step in evolutionary approaches for strain 
development. 
The molecular basis of the reconstructed strains was investigated to clarify the relationship 
between the identified mutations and the molecular changes of transcripts and metabolites in 
specific pathways. First, the overall number of differentially expressed genes was compared (Fig. 
3-7). Like the case of genetic changes, the reconstructed mutants showed a much smaller number 
of differentially expressed genes than the evolved mutants. It confirmed again that many changes 
in the evolved mutants were not necessary to reach the same phenotype. Second, the detailed 
molecular changes indicated that the mutations in the RAS2 gene induced PGM2, but not reserve 
carbohydrates metabolism (Fig. 3-8). This result indicated that there were unidentified mutations 
triggering up-regulation of reserve carbohydrates metabolism. Maybe the up-regulation of this 
metabolism was not closely related to improving galactose utilization, or there would be negative 
epistasis between the mutations in Ras/PKA signaling pathway and the unidentified mutations 
that activated the reserve carbohydrates metabolism. Both cases could explain the recovery of the 
galactose adaptive phenotype by the mutations in the RAS2 gene. Another finding is that the two 
mutations in the RAS2 gene showed substantial difference in terms of molecular changes. The 
RAU strain (RAS2
Lys 77
) showed much fewer numbers of transcriptional changes than RBU 
(RAS2
Tyr112
), while the RAU exhibited higher improvement of galactose utilization than RBU 
(Fig. 3-7). This finding again emphasized the space for further improvement of galactose 
utilization by inverse metabolic engineering. The ERG5 mutation was confirmed as a reason of 
the changes in the ergosterol pathway (Paper II).     
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Fig. 3-7. Effect of reconstructed strains compared to the evolved strains 62A and 62B by 
differentially expressed genes. Differentially expressed genes (adjust p < 0.01) are categorized as 
Venn diagrams. The functional enrichment of genes in each part was analyzed by hyper-
geometric distribution based on the KEGG, Reactome and GO term databases. Upper numbers in 
a pair of two numbers mean up-regulation and lower number mean down-regulation. 
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Fig. 3-8. Changes in the galactose and reserve carbohydrates metabolisms in the reconstructed 
strains are shown by changes in fold changes of the transcriptome and the concentration of 
carbohydrates. A: Fold changes of all genes involved in galactose and reserve carbohydrates 
metabolisms are compared to the reference strains. B: The concentrations of glycogen. C: The 
concentration of trehalose. Error bars represent standard deviation from biological duplicates. 
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3.3. Characterization of molecular mechanism of trade-offs in carbon utilization (Paper III) 
When galactose is used as a carbon source in industry, glucose would almost always also be 
present. Therefore, further characterization of the galactose-evolved mutants for growth on 
glucose was carried out. In addition, it was wondered if there was another effect from the 
obtained phenotype or traits, or there was collateral cost to get new traits. Considering the short 
adaptive evolutionary history of the evolved mutants to grow faster on galactose compared to the 
millions of year of evolution to maximize growth on glucose, a decline in glucose utilization to 
compensate for the cost of improving galactose utilization was not expected. However, 
interestingly all galactose-evolved mutants showed reduced glucose utilization (Fig. 3-9). In other 
word, the trade-off in carbon utilization between galactose and glucose was clearly detected in the 
evolved mutants. Two engineered mutants, PGM2 and SO16 strains also showed the trade-offs in 
the specific carbon uptake rate and the specific ethanol production rate (Fig. 3-9B). Since the 
genetic changes of these engineered strains were known, the genetic bases of this trade-off were 
easily identified. However, in case of evolved mutants, they showed different pattern of trade-offs, 
for example the maximum specific growth rate (Fig. 3-9A). Characterization of molecular and 
genetic bases of this trade-off was the main purpose of this study. 
 
Fig. 3-9. Fermentation physiology of the evolved mutants and the engineered mutants compared 
to the reference strain in galactose (gal) and glucose (glu) through correlation between different 
values (∆) of maximum specific growth rate and biomass yield (A), specific carbon uptake rate 
and specific ethanol production rate (B). Error bar represents standard error from biological 
duplicates in bioreactors. 
System-level analysis of evolutionary trade-off mechanism 
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Trade-offs among traits is one of the fundamental concepts in evolutionary biology. Two 
mechanisms for evolutionary trade-off have been suggested (Cooper & Lenski, 2000, Elena & 
Lenski, 2003, Wenger, et al., 2011); antagonistic pleiotropy (AP) in which the same mutation is 
related to gain and loss of adaptation in different environment, and mutations accumulation (MA) 
where different mutations are responsible for the gain and loss of adaptation. Characterization of 
the trade-off mechanisms is important in the evolutionary approach for strain development, since 
the strategy for inverse metabolic engineering will dependent on the reason for evolutionary 
trade-off, AP or MA. 
In this study, integrated genome-scale analyses were again applied to elucidate molecular 
and genetic evolutionary mechanism of the trade-off in the evolved mutants. Firstly, overall 
transcriptome profile was compared by principal component analysis; the distance between the 
evolved mutants and the reference strains looked almost identical during growth on both carbon 
sources (Fig. 3-10). This means that the evolved mutants responded to both carbon sources by 
similar transcriptional changes. More detailed molecular changes were analyzed by comparison 
of the differentially expressed genes and functional enrichment of them.  
 
Fig. 3-10. Transcriptome analysis of the evolved mutants and the reference strain in galactose 
(gal) and glucose (glu) through principal component analysis (PCA). The results are projected by 
the first three PCs, which covered 89% of the variance. 
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Fig. 3-11. Patterns of common molecular changes of the evolved mutants compared to the 
reference strain based on separation of glucose-independent and glucose-dependent. Glucose-
independent, differentially expressed genes in both carbons; glucose-dependent, differentially 
expressed genes only in glucose (A), Specific pathways and targeted metabolites in glucose-
independent (B), Specific pathways in glucose-dependent (C). Error bars in the concentration of 
glycogen and trehalose represent standard error from biological duplicates in bioreactors. 
 
Conserved pattern of transcripts in specific parts of the metabolisms and reserve 
carbohydrates were detected (Fig. 3-11); and specific molecules that were likely involved in the 
trade-off mechanism were identified such as up-regulation of 1) PGM2, 2) two non-glucose 
inducible hexokinase HXK1, GLK1 and 3) genes in reserve carbohydrates metabolism, and down 
regulation of 4) HXK2 that is one of the key enzymes of glucose metabolism and is also a 
regulator of glucose catabolic repression (Gancedo, 1998). Additionally, commonly up-regulated 
genes on growing both carbon sources had the same transcription factor (TF) binding site 
System-level analysis of evolutionary trade-off mechanism 
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(AGGGG). And TFs related to this site were Gis1p, Rph1p, Msn2/4p and Nrg1p, which are 
involved in nutrient signaling pathway (Orzechowski Westholm, et al., 2012). These results at the 
molecular level implied that antagonistic pleiotropy was the dominant mechanism for the trade-
off, and the result was loosening the tight glucose control of metabolism.  
The genetic bases of the trade-off in carbon utilization were explored. There were three 
identified mutations; two of them were confirmed as a beneficial mutation for galactose 
utilization such as mutations in the RAS2 genes, and one of them was neutral for galactose 
availability. The site-directed mutants that had each of those mutations supported antagonistic 
pleiotropy as the mechanism for trade-off (Fig. 3-12).  
 
 
Fig. 3-12. Fermentation physiology of the site-directed mutants compared to the reference strain 
in galactose (gal) and glucose (glu) through correlation between different values (∆) of maximum 
specific growth rate and biomass yield (A), specific carbon uptake rate and specific ethanol 
production rate (B). A reference strain for site-directed mutants is CEN.PK 113-5D having URA3 
marker in plasmid. Error bar represents standard error from biological duplicate on galactose in 
bioreactors and biological triplicate on glucose in baffled flasks. Longer error bars in the 
reference were from glucose culture, shorter ones came from galactose culture. 
 
The Ras/PKA signaling pathway is involved in the control of transcription factors, Gis1p, 
Rph1p, Msn2/4p and Nrg1p (Orzechowski Westholm, et al., 2012). The identified mutations in 
the RAS2 gene showed up-regulation of PGM2 in the previous study (Paper II). The mutations 
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that triggered the molecular changes in reserve carbohydrates metabolism and hexokinases are 
not still clear. There would be unidentified mutations, which mutations may adjust the change 
between maximum specific growth rate and specific glucose uptake rate, because that change was 
the main difference between the evolved mutants and the site-directed mutants containing 
mutations in the RAS2 gene. Hypothetical interpretation of the trade-off mechanism in the 
galactose evolved mutants is illustrated in Fig. 3-13.  
 
 
 
Fig. 3-13. Summary of possible molecular mechanism for the trade-off in galactose and glucose 
utilization. Colored letters (red and green) mean transcriptional change, up-regulation and down-
regulation, respectively. Gray boxes (square and arrow shape) exhibit the changes in the evolved 
mutants. A dotted box means the change only in SO16 strain (knock-out of MIG1). Dot arrows 
represent signaling flow, solid arrows represent metabolic flow. 
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4. CONCLUSIONS 
Adaptive evolution generated new strategies for improving galactose utilization in yeast 
S.cerevisiae. Those evolutionary strategies were characterized by integrated genome-scale 
analyses. Significantly, through this approach, evolutionary strategies of galactose-evolved 
mutants were elucidated at the molecular and genetic level. This characterization allowed inverse 
metabolic engineering to be more useful in evolutionary approaches for strain development. In 
addition, more characterization of the evolved mutants elucidated pleiotropy of the obtained traits. 
Through examples of this study, one could know what can be expectable or predictable in the 
application of evolutionary approaches for strain development. The most important findings in 
this Ph.D. study could be summarized as follow,  
Evolutionary changes of galactose-evolved yeast mutants can be characterized by integrated 
genome-scale analyses 
- Integration of genome scale analyses such as transcriptome, metabolome and whole-genome 
sequencing is crucial to identify the molecular and genetic basis of evolutionary changes. 
Each of these techniques does not allow for drawing comprehensive interpretation, but the 
combination of them provide a picture that enables understanding of the evolutionary 
strategies.  
- It is important to use several evolved mutants with a reference strain, because this comparison 
allow identification of conserved mutations that result in the same phenotype. Each of the 
three evolved mutants has several mutations that probably do not contribute to the evolved 
phenotype, but by identifying conserved mutations, a clear picture emerged. 
Non-canonical genetic changes results in canonical molecular changes of the evolved 
mutants 
Transcriptome and metabolome analyses lists up significantly changed metabolisms; and 
among them, molecular changes likely related to galactose metabolism were found. Whole-
genome sequencing identified several mutations, while there were no mutations in the genes or 
promoter regions that show the molecular changes. Key mutations for improving galactose 
utilization were found in non-canonical pathways.      
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- Common molecular changes in all the galactose-evolved mutants are 1) Up-regulation of 
PGM2 with reduced concentration of galactose-1-phosphate and glucose-1-phosphate, 2) Up-
regulation of reserve carbohydrates metabolism with increased concentration of trehalose and 
glycogen (Fig. 6-4). 
- Adaptive evolution of yeast on galactose generates no mutations in the galactose pathway and 
its regulatory region, which had been considered as modification targets for metabolic 
engineering; also no mutations in reserve carbohydrate metabolism.  
- A common pathway that contains mutations in all the evolved mutants was the Ras/PKA 
signaling pathway (Table 6-1). 
- Two identified mutations in the RAS2 gene result in improved galactose utilization with up-
regulation of PGM2 but not reserve carbohydrate metabolism (Fig. 6-6, Fig. 6-8). 
Importance of inverse metabolic engineering in connection with use of evolutionary 
approaches for strain development 
Few genetic and transcriptional changes are required to reach adaptive phenotypes. 
Accumulation of deleterious mutations or negative epistasis among beneficial mutations seems to 
be quite high during adaptive evolution. Therefore, inverse metabolic engineering can give a lot 
of new strategies for further engineering, such as sieving out beneficial mutations from negative 
ones and generation of new artificial combination of mutations. 
- Site-directed mutants containing only one mutation in the RAS2 gene, [Gln77→Lys] or 
[Asp
112→Tyr] show similar improvement in the specific galactose uptake rate with the 
evolved mutants; also those strains display much smaller transcription changes compared to 
the evolved mutants (Fig. 6-6, Fig. 6-7). 
- The site-directed mutant having RAS2 [Gln77→Lys] mutation even presents the highest 
specific galactose uptake rate among all the evolved and engineered strains (Fig. 6-6), and 
also relatively the highest maximum specific growth rate. 
- Two mutations in the RAS gene have different effects on galactose utilization. 
- New combinations of beneficial genetic changes almost completely recovers adaptive 
phenotypes in terms of galactose utilization, such as constitutive PGM2 over-expression on a 
plasmid combined with mutation in RAS2 [Gln
77→Lys] or [Asp112→Tyr], and in ERG5 
Conclusions 
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[Arg
370→Pro], respectively. These results indicate that new combinations of beneficial targets 
are one of the strategies for inverse metabolic engineering. 
Molecular and genetic bases of evolutionary pleiotropy: trade-offs in carbon utilization  
Galactose-evolved yeast mutants show trade-offs in carbon utilization between galactose and 
glucose. Adaptation on galactose seems to be realized by losing capacity for glucose utilization. 
The characterization results at the molecular and genetic level of this trade-off mechanism reveals 
that antagonistic pleiotropy is the dominant mechanism in the evolved mutations and this is likely 
realized by loosening the tight glucose catabolic repression system.  
- The cost for improving galactose utilization may come from diminishing glucose utilization. 
- Transcriptional changes with key metabolites of the three evolved mutants reveal antagonistic 
pleiotropy between glucose and galactose. 
- Conserved molecular changes on both carbon sources are considered underlying the 
molecular mechanism by loosening tight glucose catabolic repression such as up-regulation of 
1) PGM2, 2) non-glucose metabolism related hexokinase HXK1, GLK1 and 3) reserve 
carbohydrate metabolism; down-regulation of 4) glucose catabolic repression regulator 
HXK2; and 4) involvement of transcription factors in nutrient sensing, GIS1, RPH1, MSN2/4, 
and NRG1.   
- The mutations in the RAS2 gene indicate antagonistic pleiotropy mechanisms for trade-off in 
carbon utilization by covering the phenotypic changes of the evolved mutants on both carbon 
sources. 
- As mutations in the RAS2 gene triggered up-regulation of PGM2 and involved the 
transcription factors in nutrient sensing (Paper II), there are other unidentified mutations that 
induce transcriptional changes in the reserve carbohydrate metabolism and hexose kinases.   
- Antagonistic pleiotropy between galactose and glucose utilization by attenuation of glucose 
regulation 
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5. PERSPECTIVE 
Engineers have established significant development in the massive production of fuels and 
chemicals from petroleum and our generation is taking benefits from these technical advances. 
However, since the petroleum based production is using limited resources and generating serious 
environmental problems, our generation should prepare new technologies for the next generation, 
which uses renewable resources and alleviates environmental issues. Microbial fermentation 
processes could be one of the possible solutions, because this process utilizes biomass that is 
continuously produced with absorbing carbon dioxide in connection with its growth.  
Engineering or reconstructing of microorganisms is the requisite step for the development of 
fermentation process. The engineering of biological systems is certainly different from 
mechanical or chemical engineering, since the biology is not only vastly complicated in their 
reaction networks and regulations, but also has emergent properties. Endy suggested four 
challenges in the engineering of biological system; 1) biological complexity, 2) the tedious and 
unreliable construction and characterization of synthetic biological systems, 3) the apparent 
spontaneous physical variation of biological system behavior, 4) evolution (Endy, 2005). One of 
the strategies for engineering the microorganism is to learn and apply nature’s algorithm 
(Rothschild, 2010). Nature has produced relevant traits in specific environment; one also has used 
this valuable mechanism for making domesticated species from wild ones. Currently there are 
tools available for analysis genome-wide molecular and genetic changes. This means one can 
trace nature’s strategies for obtaining new traits.  
In this thesis, mutations in the RAS2 gene were identified as the genetic bases for improving 
galactose utilization in yeast S. cerevisiae. This result indicates two important finding. Firstly, 
these mutations were only designable by nature’s algorithm, random mutagenesis and natural 
preservation; because not only the relationship between these mutations and galactose utilization 
was not predictable, but also even though they were located in the same gene, the effects of each 
of them were vastly different. Therefore, there are still vast amounts of opportunity to find new 
strategies for strain development by evolutionary approaches. Recently, artificial mutagenesis 
methods have been developed, which are called genome engineering techniques that make it 
possible to generate random mutations on specific regions such as promoters, regulators and 
limited pathway genes (Santos & Stephanopoulos, 2008, Boyle & Gill, 2012). However, these 
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techniques still cannot cover the mutations that were found by random mutagenesis. Secondly, 
these mutations were only detectable by genome-scale analyses, since these analyses can only 
scan whole genome level changes. Of course there were still unidentified mutations that could be 
related to the changes in reserve carbohydrates metabolism and hexokinases. Whole-genome 
sequencing in this study had limitation such as incomplete coverage of whole DNA, insufficient 
coverage folds, missing copy number changes and rearrangement and so on. In spite of these 
limitations, whole genome sequencing detected the key mutations. It was also important point to 
focus on common changes by employing several parallel evolved mutants. 
In industry, a lot of mutations are normally accumulated in producing strains, because of 
long history of evolution and high mutation rate by treating mutagen. The limitation in the 
number of evolved mutants could make it difficult to find common mutations generated in the 
same gene or pathways. Therefore, identification of beneficial genetic changes is practically very 
difficult. As shown in this study, there is a possible solution, namely to do more characterization 
of the mutants at different conditions with other omics tools such as transcriptome and 
metabolome analysis. Perturbation of culture conditions could separate conserved changes from 
others. And those conserved related mutations could be the main reason for the obtained 
phenotype. For example, the galactose-evolved mutants kept the changes of transcripts and 
metabolites in specific metabolism when growing on two different carbon sources. So those 
changes could be interpretive as induced by the same mutations. This process could reduce the 
number of mutations that is involved in desired traits. 
Another point to consider is that engineering of the Ras/PKA signaling pathway might be an 
efficient way to achieve multiple phenotypes of industrial interest. Two mutations in the same 
gene showed different phenotypes, and just one mutation was enough to reach the entire adaptive 
phenotype. These results indicate that the effect of mutations in the RAS2 gene could be beyond 
the change of activity of Ras/PKA signaling pathway. In addition, when some mutations in the 
RAS2 gene were combined with PGM2 over-expression, the more diverse phenotype could be 
expectable. Therefore, constructing a mutation library of the RAS2 gene or another mutation 
library of the whole Ras/PKA signaling pathway with adjusting PGM2 expression could be very 
useful for the next step in strain development.        
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It is important to keep in mind that there are several evolutionary mechanisms or genetic 
context that may be related to strain development, such as negative epistasis and trade-offs in 
traits. These mechanisms indicate that there are many chances to lose beneficial mutations and 
their combinations. Therefore, system-level characterization of evolutionary process could detect 
more number of beneficial mutations, and one can design new combinations of them or generate 
mutation library of the identified target gene. It is crucial to accumulate the examples of 
evolutionary mechanisms at detailed molecular levels supported by genome-scale analyses for 
further advancement of the use of evolutionary engineering in industrial biotechnology. 
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